Effect of α-tocopherol on the oxidative modification of apolipoprotein E in human very-low-density lipoprotein

Bioscience, Biotechnology and Biochemistry

Volumn 67, Issue 2, 2003, Pages 402-405

  Arai, Hirofumi ^a   Uchida, Koji ^b   Fukunaga, Kenji ^c   Nagasaka, Yuji ^d   Mohri, Satoshi ^e   Furumoto, Hiroko ^a   Kuramitsu, Yasuhiro ^a   Nakamura, Kazuyuki ^a  

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NAGOYA UNIVERSITY   (Japan)

^c KANSAI MEDICAL UNIVERSITY   (Japan)

^d YAMAGUCHI PREFECTURAL UNIVERSITY   (Japan)

^e Industrial Technology Institute Miyagi Prefectural Government   (Japan)

Author keywords

Apolipoprotein E; Oxidation; Very low density lipoprotein; tocopherol

Indexed keywords

3 MORPHOLINO SYDNONIMINE; 3-MORPHOLINO-SYDNONIMINE; ALPHA TOCOPHEROL; APOLIPOPROTEIN E; COPPER SULFATE; DRUG DERIVATIVE; HEPARIN; MOLSIDOMINE; VERY LOW DENSITY LIPOPROTEIN;

ARTICLE; DRUG EFFECT; HUMAN; LIPID PEROXIDATION; METABOLISM; OXIDATION REDUCTION REACTION;

ALPHA-TOCOPHEROL; APOLIPOPROTEINS E; COPPER SULFATE; HEPARIN; HUMANS; LIPID PEROXIDATION; LIPOPROTEINS, VLDL; MOLSIDOMINE; OXIDATION-REDUCTION;

EID: 0043128961     PISSN: 09168451     EISSN: 13476947     Source Type: Journal    
DOI: 10.1271/bbb.67.402     Document Type: Article

References (25)

1. Takahashi, S., Kawarabayasi, Y., Nakai, T., Sakai, J., and Yamamoto, T., Rabbit very low density lipoprotein receptor: a low density lipoprotein receptor-like protein with distinct ligand specificity. Proc. Natl. Acad. Sci. USA, 89, 9252-9256 (1992).
2. Weisgraber, K. H., Apolipoprotein E: structure-function relationships. Adv. Protein Chem., 45, 249-302 (1994).
3. Kim, D. H., Iijima, H., Goto, K., Sakai, J., Ishii, H., Kim, H. J., Suzuki, H., Kondo, H., Saeki, S., and Yamamoto, T., Human apolipoprotein E receptor 2. A novel lipoprotein receptor of the low density lipoprotein receptor family predominantly expressed in brain. J. Biol. Chem., 271, 8373-8380 (1996).
4. Mahley, R. W., and Ji, Z. S., Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E. J. Lipid Res., 40, 1-16 (1999).
5. Halliwell, B., and Gutteridge J.M.C., Free radicals in biology and medicine, 3rd, Ed., Oxford University Press, New York (1999).
6. Steinbrecher, U. P., Zhang, H. F., and Lougheed, M., Role of oxidatively modified LDL in atherosclerosis. Free Radic. Biol. Med., 9, 155-168 (1990).
7. Berliner, J. A., and Heinecke, J. W., The role of oxidized lipoproteins in atherogenesis. Free Radic. Biol. Med., 20, 707-727 (1996).
8. Esterbauer, H., Schmidt, R., and Hayn, M., Relationships among oxidation of low-density lipoprotein, antioxidant protection, and atherosclerosis. Adv. Pharmacol., 38, 425-456 (1997).
9. Steinberg, D., Low density lipoprotein oxidation and its pathobiological significance. J. Biol. Chem., 272, 20963-20966 (1997).
10. Mohr, D., and Stocker, R., Radical-mediated oxidation of isolated human very-low-density lipoprotein. Arterioscler. Thromb., 14, 1186-1192 (1994).
11. Arai, H., Kashiwagi, S., Nagasaka, Y., Uchida, K., Hoshii, Y., and Nakamura, K., Oxidative modification of apolipoprotein E in human very-low-density lipoprotein and its inhibition by glycosaminoglycans. Arch. Biochem. Biophys., 367, 1-8 (1999).
12. Halliwell, B., Free radicals and antioxidants: a personal view. Nutr. Rev., 52, 253-265 (1994).
13. Stahl, W., and Sies, H., Antioxidant defense: vitamins E and C and carotenoids. Diabetes, 46 Suppl 2, S14-18 (1997).
14. Patel, R. P., and Darley-Usmar, V. M., Using perox-ynitrite as oxidant with low-density lipoprotein. Methods Enzymol., 269, 375-384 (1996).
15. Hatch, F. T., Practical methods for plasma lipoprotein analysis. Adv. Lipid Res., 6, 1-68 (1968).
16. Arai, H., Terao, J., Abdalla, D. S., Suzuki, T., and Takama, K., Coulometric detection in high-performance liquid chromatographic analysis of cholesteryl ester hydroperoxides. Free Radic. Biol. Med., 20, 365-371 (1996).
17. Kikugawa, K., Kojima, T., Yamaki, S., and Kosugi, H., Interpretation of the thiobarbituric acid reactivity of rat liver and brain homogenates in the presence of ferric ion and ethylenediaminetetraacetic acid. Anal. Biochem., 202, 249-255 (1992).
18. Da Silva, E. L., Piskula, M., and Terao, J., Enhancement of antioxidative ability of rat plasma by oral administration of (-)-epicatechin. Free Radic. Biol. Med., 24, 1209-1216 (1998).
19. Laemmli, U. K., Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227, 680-685 (1970).
20. Pryor, W. A., and Porter, N. A., Suggested mechanisms for the production of 4-hydroxy-2-nonenal from the autoxidation of polyunsaturated fatty acids. Free Radic. Biol. Med., 8, 541-543 (1990).
21. Esterbauer, H., Schaur, R. J., and Zollner, H., Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic. Biol. Med., 11, 81-128 (1991).
22. Mahley, R. W., Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science, 240, 622-630 (1988).
23. Cardin, A. D., Demeter, D. A., Weintraub, H. J., and Jackson, R. L., Molecular design and modelling of protein-heparin interactions. Methods Enzymol., 203, 556-583 (1991).
24. e-(hexanonyl)lysine in protein exposed to lipid hydroperoxide. A plausible marker for lipid hydroperoxide-derived protein modification. J. Biol. Chem., 274, 20406-20414 (1999).
25. Uchida, K., Toyokuni, S., Nishikawa, K., Kawakishi, S., Oda, H., Hiai, H., and Stadtman, E. R., Michael addition-type 4-hydroxy-2-nonenal adducts in modified low-density lipoproteins: markers for atherosclerosis. Biochemistry, 33, 12487-12494 (1994)